scispace - formally typeset
Open AccessJournal ArticleDOI

Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

Stephen H. Leppla
- 01 May 1982 - 
- Vol. 79, Iss: 10, pp 3162-3166
Reads0
Chats0
TLDR
It is shown here that EF is an adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1] produced by Bacillus anthracis in an inactive form and nearly equals that of the most active known cyclase.
Abstract: 
Anthrax toxin is composed of three proteins: protective antigen (PA), lethal factor (LF), and edema factor (EF). These proteins individually cause no known physiological effects in animals but in pairs produce two toxic actions. Injection of PA with LF causes death of rats in 60 min, whereas PA with EF causes edema in the skin of rabbits and guinea pigs. The mechanisms of action of these proteins have not been determined. It is shown here that EF is an adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] produced by Bacillus anthracis in an inactive form. Activation occurs upon contact with a heat-stable eukaryotic cell material. The specific activity of the resulting adenylate cyclase nearly equals that of the most active known cyclase. In Chinese hamster ovary cells exposed to PA and EF, cAMP concentrations increase without a lag to values about 200-fold above normal, remain high in the continued presence of toxin, and decrease rapidly after its removal. The increase in cAMP is completely blocked by excess LF. It is suggested that PA interacts with cells to form a receptor system by which EF and perhaps LF gain access to the cytoplasm.

read more

Citations
More filters
Journal ArticleDOI

Membrane type-1 matrix metalloproteinase (MT1-MMP) protects malignant cells from tumoricidal activity of re-engineered anthrax lethal toxin.

TL;DR: It is inferred from the studies that synthetic inhibitors of MMPs are likely to increase the therapeutic anti-cancer effect of anthrax toxin and a unique role of furin in the activation of PA is supported, thereby suggesting that furin inhibitors are the likely specific drugs for short-term therapy of Anthrax infection.
Journal ArticleDOI

Anthrax vaccine recipients lack antibody against the loop neutralizing determinant: A protective neutralizing epitope from Bacillus anthracis protective antigen

TL;DR: The elicitation of LND-specific antibody in humans appears to require immunization with an epitope-focused vaccine, and AVA-vaccinees have a low frequency of antibody reactive with the LND.
Journal ArticleDOI

Anthrax Edema Toxin Impairs Clearance in Mice

TL;DR: The data suggest that in vivo, ET alters circulatory protein and small molecule pharmacokinetics by an as-yet-undefined mechanism, thereby potentially allowing a prolonged circulation of anthrax virulence factors such as EF during infection.
Journal ArticleDOI

Inactivation of Rho GTPases by Statins Attenuates Anthrax Lethal Toxin Activity

TL;DR: It is shown that statins delay LT-induced death and MKK cleavage in RAW macrophages and that statin-mediated effects on LT action are attributable to disruption of Rho GTPases.
Journal ArticleDOI

Bordetella pertussis adenylate cyclase inactivation by the host cell

TL;DR: It is reported here that treatment of human lymphocytes with a glycolysis inhibitor and an uncoupler of oxidative phosphorylation completely blocked the intracellular inactivation of B. pertussis AC.
References
More filters
Journal Article

Protein Measurement with the Folin Phenol Reagent

TL;DR: Procedures are described for measuring protein in solution or after precipitation with acids or other agents, and for the determination of as little as 0.2 gamma of protein.
Journal ArticleDOI

Restoration of Several Morphological Characteristics of Normal Fibroblasts in Sarcoma Cells Treated with Adenosine-3':5'-Cyclic Monophosphate and Its Derivatives

TL;DR: The data suggest that cyclic AMP may be an important factor in the determination of morphology of normal fibroblasts and this function may be lost or altered during transformation.
Journal ArticleDOI

Activation of adenylate cyclase by choleragen.

J Moss, +1 more
- 01 Jan 1979 - 
TL;DR: An attempt is made to evaluate the mechanism of action of NAD Glycohydrolase and ADP-Ribosyltransferase on GTP-Binding Protein and GTPase Activity in response to the presence of Gangliosides and Their Oligosaccharides in Choleragen.
Journal ArticleDOI

A Permeability Factor (Toxin) found in Cholera Stools and Culture Filtrates and its Neutralization by Convalescent Cholera Sera.

TL;DR: A Permeability Factor (Toxin) found in Cholera Stools and Culture Filtrates and its Neutralization by Convalescent CholERA Sera is found to be neutralized by convalescent cholera patients.
Related Papers (5)